Table. Monovalent hepatitis B vaccines for adolescents and adults
|
Vaccine |
Age of vaccine recipient (years) |
Dose (hepatitis B surface antigen protein) |
Number of doses |
Recommended schedule minimum intervals |
Alternative schedule minimum intervals |
|---|---|---|---|---|---|
|
Engerix-B (adult formulation) |
11–15 only |
20 μg |
2 |
|
Not applicable |
| Engerix-B (paediatric formulation) | <20 | 10 μg | 3 |
|
OR
|
|
Engerix-B (adult formulation) |
≥20 |
20 μg |
3 |
|
or
|
|
H-B-Vax II (adult formulation) |
11–15 only |
10 μg |
2 |
|
Not applicable |
| H-B-Vax II (paediatric formulation) | <20 | 5 μg | 3 |
|
OR
|
|
H-B-Vax II (adult formulation) |
≥20 |
10 μg |
3 |
|
or
|
|
H-B-Vax II (dialysis formulation) |
≥20 |
40 μg |
3 |
|
Not applicable |